In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

November 27, 2014

Boston, MA 11/27/2014 (wallstreetpr) – Avanir Pharmaceuticals Inc (NASDAQ:AVNR) suffered a blow this week when the U.S. Food and Drug Administration declined to approve its migraine drug device. The company had sought marketing approval for the device, which in many ways has good revenue promise. However, even though the FDA rejectedRead More

In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

November 27, 2014

Boston, MA 11/27/2014 (wallstreetpr) – Avanir Pharmaceuticals Inc (NASDAQ:AVNR) suffered a blow this week when the U.S. Food and Drug Administration declined to approve its migraine drug device. The company had sought marketing approval for the device, which in many ways has good revenue promise. However, even though the FDA rejectedRead More

Elon Musk Defends Tesla Motors Inc. (NASDAQ:TSLA)-Nevada Gigafactory Deal

Elon Musk Defends Tesla Motors Inc. (NASDAQ:TSLA)-Nevada Gigafactory Deal

November 23, 2014

Boston, MA 11/23/2014 (wallstreetpr) –  Tesla Motors Inc. (NASDAQ:TSLA) CEO, Elon Musk, has defended the company’s decision to award Nevada the rights for the construction of the multi-billion battery factory. Musk was responding to claims that the company had used clever machinations into acquiring a bumper package incentive from theRead More

In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

November 27, 2014

Boston, MA 11/27/2014 (wallstreetpr) – Avanir Pharmaceuticals Inc (NASDAQ:AVNR) suffered a blow this week when the U.S. Food and Drug Administration declined to approve its migraine drug device. The company had sought marketing approval for the device, which in many ways has good revenue promise. However, even though the FDA rejectedRead More